Specimen SS-F-AST-352 // ASTRINGENCY · IFI-A
Catechin Profile Optimization IV-IV-B
Camellia sinensis
Tea
Target Trait
3.43×
fold-change
EGCG:ECG:EC catechin molar ratio index
Technical Specifications
SKU
SS-F-AST-352
Genomic Edits
8
GC Content
46.2%
Construct Length
4,348 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Receptor Target
Polyphenol-astringency axis
IFI Score
343
Pathway Edits
- ANR differential expression (anthocyanidin reductase) for epicatechin flux control
- LAR allelic balancing (leucoanthocyanidin reductase) for catechin:epicatechin ratio
- F3-5H overexpression (flavonoid 3',5'-hydroxylase) for gallated catechin precursor enrichment
- DFR allelic selection for 3',4'- vs 3',4',5'-dihydroxyl substrate preference
- FLS suppression (flavonol synthase) to redirect dihydroflavonol flux toward catechins
- Cell-free wheat germ extract reconstitution system
- Enhanced flux via 5'UTR synthetic leader sequence optimization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Industrial EGCG ingredient extraction, premium specialty tea formulation, pharmaceutical catechin precursor production. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.
License
$4049 · Tier IV License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?